Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843.
Article
PubMed
Google Scholar
Vargas-Uricoechea H, Casas-Figueroa LÁ. An epidemiologic analysis of diabetes in Colombia. Ann Glob Health. 2015;81:742–53.
Article
PubMed
Google Scholar
Harding JL, Pavkov ME, Magliano DJ, Shaw JE, Gregg EW. Global trends in diabetes complications: a review of current evidence. Diabetologia. 2019;62:3–16.
Article
PubMed
Google Scholar
Herman WH, Braffett BH, Kuo S, Lee JM, Brandle M, Jacobson AM, et al. What are the clinical, quality-of-life, and cost consequences of 30 years of excellent vs. poor glycemic control in type 1 diabetes? J Diabetes Complicat. 2018;32:911–5.
Article
Google Scholar
Zoungas S, Arima H, Gerstein HC, Holman RR, Woodward M, Reaven P, et al. Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials. Lancet Diabetes Endocrinol. 2017;5:431–7.
Article
PubMed
Google Scholar
Ray KK, Seshasai SRK, Wijesuriya S, Sivakumaran R, Nethercott S, Preiss D, et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet. 2009;373:1765–72.
Article
CAS
PubMed
Google Scholar
Hayward RA, Reaven PD, Wiitala WL, Bahn GD, Reda DJ, Ge L, et al. Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2015;372:2197–206.
Article
CAS
PubMed
Google Scholar
Mannucci E, Monami M, Dicembrini I, Piselli A, Porta M. Achieving HbA1c targets in clinical trials and in the real world: a systematic review and meta-analysis. J Endocrinol Investig. 2014;37:477–95.
Article
CAS
Google Scholar
De Pablos-Velasco P, Parhofer KG, Bradley C, Eschwège E, Gönder-Frederick L, Maheux P, et al. Current level of glycaemic control and its associated factors in patients with type 2 diabetes across Europe: Data from the PANORAMA study. Clin Endocrinol (Oxf). 2014;80:47–56.
Article
CAS
Google Scholar
Smalls BL, Ritchwood TD, Bishu KG, Egede LE. Racial/ethnic differences in glycemic control in older adults with type 2 diabetes: United States 2003–2014. Int J Environ Res Public Health. 2020;17:950.
Article
PubMed Central
Google Scholar
Suh DC, Choi IS, Plauschinat C, Kwon J, Baron M. Impact of comorbid conditions and race/ethnicity on glycemic control among the US population with type 2 diabetes, 1988-1994 to 1999-2004. J Diabetes Complicat. 2010;24:382–91.
Article
Google Scholar
Chetoui A, Kaoutar K, Elmoussaoui S, Boutahar K, El Kardoudi A, Chigr F, et al. Prevalence and determinants of poor glycaemic control: a cross-sectional study among Moroccan type 2 diabetes patients. Int Health. 2020;00:1–8.
Google Scholar
Iglay K, Hannachi H, Howie PJ, Xu J, Li X, Engel SS, et al. Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus. Curr Med Res Opin. 2016;32:1243–52.
Article
PubMed
Google Scholar
Luijks H, Biermans M, Bor H, van Weel C, Lagro-Janssen T, de Grauw W, et al. The effect of comorbidity on glycemic control and systolic blood pressure in type 2 diabetes: a cohort study with 5 year follow-up in primary care. PLoS One. 2015;10:e0138662.
Article
PubMed
PubMed Central
CAS
Google Scholar
Bralić Lang V, Bergman MB. Prevalence of comorbidity in primary care patients with type 2 diabetes and its association with elevated HbA1c: a cross-sectional study in Croatia. Scand J Prim Health Care. 2016;34:66–72.
Article
PubMed
PubMed Central
Google Scholar
Hudon C. Comorbidity and glycemia control among patients with type 2 diabetes in primary care. Diabetes Metab Syndr Obes Targets Ther. 2008;1:33–7.
Article
CAS
Google Scholar
Almetwazi M, Alwhaibi M, Balkhi B, Almohaini H, Alturki H, Alhawassi T, et al. Factors associated with glycemic control in type 2 diabetic patients in Saudi Arabia. Saudi Pharm J. 2019;27:384–8.
Article
PubMed
Google Scholar
Alzaheb R, Altemani A. The prevalence and determinants of poor glycemic control among adults with type 2 diabetes mellitus in Saudi Arabia. Diabetes Metab Syndr Obes Targets Ther. 2018;11:15–21.
Article
Google Scholar
Ministerio de Salud y Proteccion Social - Republica de Colombia. Resolucion 2643 del 2014; 2014. p. 1–13. https://cuentadealtocosto.org/site/wp-content/uploads/2019/10/Resolucion-02463-de-2014-ERC.pdf. Accessed 9 Oct 2020
Google Scholar
Ministerio de Salud y Proteccion Social - Republica de Colombia. Cifras de aseguramiento en salud con corte diciembre 2020. 2020. https://www.minsalud.gov.co/proteccionsocial/Paginas/cifras-aseguramiento-salud.aspx. Accessed 19 Jan 2021.
Google Scholar
Ministerio de Salud y Protección Social de Colombia. Guía de práctica clínica Hipertensión arterial primaria (HTA). 2013. https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/INEC/IETS/GPC_Completa_HTA.pdf. Accessed 22 Apr 2021.
Google Scholar
Ministerio de Salud y Protección Social de Colombia. Guía de Práctica Clínica para el manejo de la hipertensión arterial primaria (HTA). 2017; 2da edición. Guía No.18. http://gpc.minsalud.gov.co/gpc_sites/Repositorio/Conv_500/GPC_hta/gpc_hta_profesionales.aspx. Accessed 22 Apr 2021.
Ministerio de Salud y Protección Social de Colombia. Guía de Práctica Clínica para el diagnóstico y tratamiento de la Enfermedad Renal Crónica (adopción). 2016. http://gpc.minsalud.gov.co/gpc_sites/Repositorio/Otros_conv/GPC_e_renal/gpc_e_renal_completa.aspx. Accessed 22 Apr 2021.
Google Scholar
WHO Consultation on Obesity (1999:Geneva Switzerland) & World Health Organization. Obesity: Preventing and managing the global epidemic: Report of a WHO Consultation (WHO Technical Report Series 894). 2000:1-252. https://apps.who.int/iris/handle/10665/42330. Accessed 9 Oct 2020.
American Diabetes Association. 6. Glycemic Targets: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020;43(Suppl. 1):S66–76.
Article
Google Scholar
Departamento Administrativo Nacional de Estadistica (DANE). Cuentas departamentales, Producto Interno Bruto por departamento 2019 preliminar; 2020. p. 7–8. https://www.dane.gov.co/files/investigaciones/pib/departamentales/B_2015/Bol_dptal_2019preliminar.pdf. Accessed 10 Nov 2020
Google Scholar
Levey AS, Stevens LA, Schmid CH, Zhang Y (Lucy), Castro AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–12.
Article
PubMed
PubMed Central
Google Scholar
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1–150.
Google Scholar
Yang D, Dalton JE. A unified approach to measuring the effect size between two groups using SAS®. SAS Glob Forum Stat Data Anal. 2012;335:1–6.
Google Scholar
Wilmot E, Idris I. Early onset type 2 diabetes: risk factors, clinical impact and management. Ther Adv Chronic Dis. 2014;5:234–44.
Article
PubMed
PubMed Central
Google Scholar
Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int. 2020;98:S1–115.
Article
Google Scholar
Sosa-Rubí SG, Galárraga O, López-Ridaura R. Diabetes treatment and control: the effect of public health insurance for the poor in Mexico. Bull World Health Organ. 2009;87:512–9.
Article
PubMed
PubMed Central
Google Scholar
Zhang X, McKeever Bullard K, Gregg EW, Beckles GL, Williams DE, Barker LE, et al. Access to health care and control of ABCS of diabetes. Diabetes Care. 2012;35:1566–71.
Article
PubMed
PubMed Central
Google Scholar
Ministerio de Salud y Protección Social de Colombia. Todo lo que usted debe saber sobre el plan de beneficios POS. 2014. https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VP/RBC/todo-lo-que-usted-debe-saber-sobre-el-plan-de-beneficios.pdf. Accessed 7 May 2021.
Google Scholar
Copur S, Onal EM, Afsar B, Ortiz A, van Raalte DH, Cherney DZ, et al. Diabetes mellitus in chronic kidney disease: biomarkers beyond HbA1c to estimate glycemic control and diabetes-dependent morbidity and mortality. J Diabetes Complicat. 2020;34:107707.
Article
Google Scholar
De Cosmo S, Viazzi F, Pacilli A, Giorda C, Ceriello A, Gentile S, et al. Achievement of therapeutic targets in patients with diabetes and chronic kidney disease: insights from the Associazione Medici Diabetologi annals initiative. Nephrol Dial Transplant. 2015;30:1526–33.
Article
PubMed
CAS
Google Scholar
Bae JP, Lage MJ, Mo D, Nelson DR, Hoogwerf BJ. Obesity and glycemic control in patients with diabetes mellitus: analysis of physician electronic health records in the US from 2009-2011. J Diabetes Complicat. 2016;30:212–20.
Article
CAS
Google Scholar
Speeckaert M, Van Biesen W, Delanghe J, Slingerland R, Wiecek A, Heaf J, et al. Are there better alternatives than haemoglobin A1c to estimate glycaemic control in the chronic kidney disease population? Nephrol Dial Transplant. 2014;29:2167–77.
Article
CAS
PubMed
Google Scholar
Hill CJ, Maxwell AP, Cardwell CR, Freedman BI, Tonelli M, Emoto M, et al. Glycated hemoglobin and risk of death in diabetic patients treated with hemodialysis: a meta-analysis. Am J Kidney Dis. 2014;63:84–94.
Article
CAS
PubMed
Google Scholar
Kuo I-C, Lin HY-H, Niu S-W, Hwang D-Y, Lee J-J, Tsai J-C, et al. Glycated hemoglobin and outcomes in patients with advanced diabetic chronic kidney Disease. Sci Rep. 2016;6:20028.
Article
CAS
PubMed
PubMed Central
Google Scholar
Esteghamati A, Ismail-Beigi F, Khaloo P, Moosaie F, Alemi H, Mansournia MA, et al. Determinants of glycemic control: phase 2 analysis from nationwide diabetes report of National Program for prevention and control of diabetes (NPPCD-2018). Prim Care Diabetes. 2020;14:222–31.
Article
PubMed
Google Scholar
Gummesson A, Nyman E, Knutsson M, Karpefors M. Effect of weight reduction on glycated haemoglobin in weight loss trials in patients with type 2 diabetes. Diabetes Obes Metab. 2017;19:1295–305.
Article
CAS
PubMed
Google Scholar
Lerman-Garber I, Aguilar-Salinas C, Tusié-Luna T, Velásquez D, Lobato-Valverde M, Osornio-Flores M, et al. Diabetes tipo 2 de inicio temprano. Experiencia en una institución de tercer nivel de atención médica. Gac Med Mex. 2010;146:179–84.
PubMed
Google Scholar
Bo A, Thomsen RW, Nielsen JS, Nicolaisen SK, Beck-Nielsen H, Rungby J, et al. Early-onset type 2 diabetes: age gradient in clinical and behavioural risk factors in 5115 persons with newly diagnosed type 2 diabetes-results from the DD2 study. Diabetes Metab Res Rev. 2018;34:e2968.
Article
CAS
Google Scholar
Gopalan A, Mishra P, Alexeeff SE, Blatchins MA, Kim E, Man A, et al. Initial glycemic control and care among younger adults diagnosed with type 2 diabetes. Diabetes Care. 2020;43:975–81.
Article
CAS
PubMed
PubMed Central
Google Scholar
Badedi M, Solan Y, Darraj H, Sabai A, Mahfouz M, Alamodi S, et al. Factors associated with long-term control of type 2 diabetes mellitus. J Diabetes Res. 2016;2016:2109542.
Article
PubMed
PubMed Central
CAS
Google Scholar
Menzin J, Korn JR, Cohen J, Lobo F, Zhang B, Friedman M, et al. Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus. J Manag Care Pharm. 2010;16:264–75.
PubMed
Google Scholar
Gil J, Sicras-Mainar A, Zucchelli E. Uncontrolled diabetes and health care utilisation: panel data evidence from Spain. Eur J Health Econ. 2018;19:785–95.
Article
PubMed
Google Scholar
Mata-Cases M, Rodríguez-Sánchez B, Mauricio D, Real J, Vlacho B, Franch-Nadal J, et al. The association between poor glycemic control and health care costs in people with diabetes: a population-based study. Diabetes Care. 2020;43:751–8.
Article
PubMed
Google Scholar